Clinical and molecular characterization of HER2 amplified-pancreatic cancer

BACKGROUND: Pancreatic cancer is one of the most lethal and molecularly diverse malignancies. Repurposing of therapeutics that target specific molecular mechanisms in different disease types offers potential for rapid improvements in outcome. Although HER2 amplification occurs in pancreatic cancer,...

Descripción completa

Detalles Bibliográficos
Autores principales: Chou, Angela, Waddell, Nicola, Cowley, Mark J, Gill, Anthony J, Chang, David K, Patch, Ann-Marie, Nones, Katia, Wu, Jianmin, Pinese, Mark, Johns, Amber L, Miller, David K, Kassahn, Karin S, Nagrial, Adnan M, Wasan, Harpreet, Goldstein, David, Toon, Christopher W, Chin, Venessa, Chantrill, Lorraine, Humphris, Jeremy, Mead, R Scott, Rooman, Ilse, Samra, Jaswinder S, Pajic, Marina, Musgrove, Elizabeth A, Pearson, John V, Morey, Adrienne L, Grimmond, Sean M, Biankin, Andrew V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978667/
https://www.ncbi.nlm.nih.gov/pubmed/24004612
http://dx.doi.org/10.1186/gm482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978667/
https://www.ncbi.nlm.nih.gov/pubmed/24004612
http://dx.doi.org/10.1186/gm482

Ejemplares similares